Correlation Between Anika Therapeutics and Guided Therapeutics
Can any of the company-specific risk be diversified away by investing in both Anika Therapeutics and Guided Therapeutics at the same time? Although using a correlation coefficient on its own may not help to predict future stock returns, this module helps to understand the diversifiable risk of combining Anika Therapeutics and Guided Therapeutics into the same portfolio, which is an essential part of the fundamental portfolio management process.
By analyzing existing cross correlation between Anika Therapeutics and Guided Therapeutics, you can compare the effects of market volatilities on Anika Therapeutics and Guided Therapeutics and check how they will diversify away market risk if combined in the same portfolio for a given time horizon. You can also utilize pair trading strategies of matching a long position in Anika Therapeutics with a short position of Guided Therapeutics. Check out your portfolio center. Please also check ongoing floating volatility patterns of Anika Therapeutics and Guided Therapeutics.
Diversification Opportunities for Anika Therapeutics and Guided Therapeutics
-0.51 | Correlation Coefficient |
Excellent diversification
The 3 months correlation between Anika and Guided is -0.51. Overlapping area represents the amount of risk that can be diversified away by holding Anika Therapeutics and Guided Therapeutics in the same portfolio, assuming nothing else is changed. The correlation between historical prices or returns on Guided Therapeutics and Anika Therapeutics is a relative statistical measure of the degree to which these equity instruments tend to move together. The correlation coefficient measures the extent to which returns on Anika Therapeutics are associated (or correlated) with Guided Therapeutics. Values of the correlation coefficient range from -1 to +1, where. The correlation of zero (0) is possible when the price movement of Guided Therapeutics has no effect on the direction of Anika Therapeutics i.e., Anika Therapeutics and Guided Therapeutics go up and down completely randomly.
Pair Corralation between Anika Therapeutics and Guided Therapeutics
Given the investment horizon of 90 days Anika Therapeutics is expected to under-perform the Guided Therapeutics. But the stock apears to be less risky and, when comparing its historical volatility, Anika Therapeutics is 5.92 times less risky than Guided Therapeutics. The stock trades about -0.03 of its potential returns per unit of risk. The Guided Therapeutics is currently generating about 0.06 of returns per unit of risk over similar time horizon. If you would invest 33.00 in Guided Therapeutics on September 4, 2024 and sell it today you would lose (17.00) from holding Guided Therapeutics or give up 51.52% of portfolio value over 90 days.
| Time Period | 3 Months [change] |
| Direction | Moves Against |
| Strength | Very Weak |
| Accuracy | 100.0% |
| Values | Daily Returns |
Anika Therapeutics vs. Guided Therapeutics
Performance |
| Timeline |
| Anika Therapeutics |
| Guided Therapeutics |
Anika Therapeutics and Guided Therapeutics Volatility Contrast
Predicted Return Density |
| Returns |
Pair Trading with Anika Therapeutics and Guided Therapeutics
The main advantage of trading using opposite Anika Therapeutics and Guided Therapeutics positions is that it hedges away some unsystematic risk. Because of two separate transactions, even if Anika Therapeutics position performs unexpectedly, Guided Therapeutics can make up some of the losses. Pair trading also minimizes risk from directional movements in the market. For example, if an entire industry or sector drops because of unexpected headlines, the short position in Guided Therapeutics will offset losses from the drop in Guided Therapeutics' long position.| Anika Therapeutics vs. Axogen Inc | Anika Therapeutics vs. Orthofix Medical | Anika Therapeutics vs. SurModics | Anika Therapeutics vs. Paragon 28 |
| Guided Therapeutics vs. Nephros | Guided Therapeutics vs. Intelgenx Technologs | Guided Therapeutics vs. SANUWAVE Health | Guided Therapeutics vs. Spectrascience New |
Check out your portfolio center.Note that this page's information should be used as a complementary analysis to find the right mix of equity instruments to add to your existing portfolios or create a brand new portfolio. You can also try the Performance Analysis module to check effects of mean-variance optimization against your current asset allocation.
Other Complementary Tools
| Analyst Advice Analyst recommendations and target price estimates broken down by several categories | |
| Portfolio Rebalancing Analyze risk-adjusted returns against different time horizons to find asset-allocation targets | |
| Watchlist Optimization Optimize watchlists to build efficient portfolios or rebalance existing positions based on the mean-variance optimization algorithm | |
| Piotroski F Score Get Piotroski F Score based on the binary analysis strategy of nine different fundamentals | |
| Premium Stories Follow Macroaxis premium stories from verified contributors across different equity types, categories and coverage scope |